Prevention Before Cure

Research shows that traditional lipid testing alone (total cholesterol, triglycerides, LDL-cholesterol and HDL-cholesterol) fails to provide critical information that physicians need in order to understand causative factors and effectively treat disease. By simultaneously probing multiple biological pathways that underlie the disease process, our comprehensive advanced laboratory testing can help identify where a patient sits on the disease continuum for cardiovascular disease, diabetes, and metabolic syndrome.

My Health Counts uses a scientific approach to identify hidden health risks early with Advanced Laboratory Testing and then empowers patients to improve their health using proven engagement strategies.

  • Advanced Laboratory Test
    • Comprehensive data including more than 25 health risk markers that are uniquely grouped to help uncover hidden risk
    • Evidence-based scientific data that has been published in peer-reviewed journals
    • Actionable data that is condition-specific to prevent disease
    • Learn more
  • Patient Engagement
    • Consumer-friendly format of lab report
      • Groupings of health markers
      • Color-coding: red, yellow, green
      • Patient-centric comments/interpretation of lab results
    • Clinical Health Consulting
    • Web portal with digital tools
  • Health Outcomes Reporting
    • Provides tracking and reporting data to show health outcomes for your patient population

How We Work With You

Advanced laboratory testing helps medical professionals identify hidden risk markers for cardiovascular disease and diabetes, and improve outcomes for the secondary prevention patient population.

Cardiac Rehab »

Following a cardiovascular event, cardiac rehabilitation clinical teams use our advanced laboratory testing to identify hidden risks for CVD and related conditions, like diabetes, that impact cardiovascular health. This additional information along with patient-centered education can help to improve treatment, prevent another event, and reduce costly re-admissions. Additionally, HDL, Inc. will work with the cardiac rehab team to incorporate and track quality improvement strategies and appropriate outcomes.

Our advanced lab testing and population health improvement model are also ideal for integrated care models, like accountable care organizations (ACOs) or on-site clinics for employer groups with a focus on measurable health outcomes and prevention of disease.

We also work with employer groups to support their company’s health improvement strategy.

Health Outcomes Case Study

In working with cardiac rehab populations, HDL, Inc.’s Advanced Laboratory Testing has helped medical professionals identify hidden risk factors that are not revealed through traditional testing methods. For example, lab results for a group of 99 cardiac rehab patients show that the traditional lipid test with LDL-C indicates only 9% have high risk values.

However, Advanced Laboratory Testing reveals a more complete picture to guide treatment. Some of the additional markers for this same group of cardiac rehab patients show:

  • 53% at high risk with the inherited trait Lp(a) which is causally related to cardiovascular disease
  • While only a small percentage of LDL levels are elevated, Apo B and LDL-P are increased and are better risk predictors for cardiovascular disease
  • Nearly 50% have insulin levels often seen in prediabetes before traditional screening methods would detect risk

Population Health Scientific Studies

Testimonial

“Almost every abnormality indicated by biomarkers on the HDL, Inc. report is correctable, with dietary and lifestyle changes, or drug therapy. This gives the testing incredible value, and is especially satisfying from a provider standpoint as one can actually make a difference.”

Tara Dall, M.D., Chief Medical Director, Health Diagnostic Laboratory, Inc.

Meet the Team

  • Tara Dall, MD
    Chief Medical Officer
    • Graduated in the first class of Diplomates of the American Board of Clinical Lipidology. In 2007 her clinic achieved national recognition as the first fully certified Level II lipid clinic in the United States
    • Attended University of Wisconsin-Madison for undergraduate, medical school training, and family medicine residency. Entering private practice in 2001, she formed the Cholesterol & Lifestyle Center in 2006 with the goal of aggressive detection and treatment of atherosclerotic cardiovascular disease.
    • In 2008 she formed Advanced Lipidology, Early Detection Center for Heart Disease and Diabetes. A published author in the field of lipidology, she has also been involved in CIMT research in collaboration with University of Wisconsin-Madison.
  • Szilard Voros, MD
    Chief Academic Officer
    • Medical director for Cardiovascular Magnetic Resonance (CMR) and Computed Tomography (CCT) at the Fuqua Heart Center of Atlanta at Piedmont Hospital; published extensively in clinical as well as investigational aspects of CMR and CCT
    • Graduate of University Medical School of Pecs in Hungary; completed internal medicine internship and residency at University of Alabama at Birmingham where he served as a Chief Medical Resident, and his fellowship at the University of Virginia, where he served as Chief Cardiovascular Fellow
    • Founding member of the Society for Cardiovascular Computed Tomography (SCCT) and member of the Society for Cardiovascular Magnetic Resonance (SCMR), Society for Cardiovascular Magnetic Resonance, American College of Cardiology, American Medical Association and American College of Physicians
  • Anna McKean
    Executive Vice President, Strategic Initiatives
    • Leads a team that develops and delivers solutions for improving population health for clients that include employers, first responders, and health systems.
    • More than 25 years of experience including serving as President of a successful healthcare start-up company and leading a profitable consulting practice for KPMG.
    • Director for the Virginia Center for Healthcare Innovation, Association for Corporate Growth, Richmond Chapter, and President of the Sherwood Anderson Foundation.
    • Graduate of University of Richmond and Virginia Commonwealth University and enjoys travel with husband and two daughters.
  • Terry Thomas, RN, MSN
    Clinical Director, Strategic Initiatives
    • More than 20 years’ experience as clinician in cardiovascular nursing and preventive cardiology; leader in developing lipid clinics and heart disease prevention programs
    • Developed one of the first Women’s Heart Disease Prevention programs in the country at the University of North Carolina at Chapel Hill
    • Founding member of the Preventive Cardiovascular Nurses Association and the initial nurse leader on the board of the Southeast Lipid Association

Close [X]

We look forward to hearing from you. Reach us by phone at (877) 443-5227 ext. 3470, email us at MyHealthCounts@hdlabinc.com, or submit your contact information below.








Fields marked with an * are required.